| 中文名称： | VX-745 |
| 中文别名： | 5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基)-6H-嘧啶并[1,6-b]哒嗪-6-酮;4-肼基-N-甲基苯基乙烷磺酰胺盐酸盐;VX745 抑制剂 |
| smiles： | ClC1C([H])=C([H])C([H])=C(C=1C1C(N=C([H])N2C=1C([H])=C([H])C(=N2)SC1C([H])=C([H])C(=C([H])C=1F)F)=O)Cl |
| 英文名称： | VX-745 |
| 英文别名： | 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-b]pyridazin-6-one;5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyridazino[6,1-f]pyrimidin-6-one;VX-745;5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido(1,6-b)pyridazin-6-one;5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)-thio)-6H-pyrimido[1,6-b]pyridazin-6-one;5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one;6H-PYRIMIDO[1,6-B]PYRIDAZIN-6-ONE, 5-(2,6-DICHLOROPHENYL)-2-[(2,4-DIFLUOROPHENYL)THIO]- (9CI);6H-Pyrimido[1,6-b]pyridazin-6-one,5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-;VX 745;5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one;Neflamapimod;VX745;TYL52QM320;Neflamapimod [USAN];Neflamapimod (USAN);C19H9Cl2F2N3OS;6H-Pyrimido[1,6-b]pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-;5T-0205;SCHEMBL156367;NCGC00241111-12;HMS3654L10;5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-a]pyridazin-6-one;MLS006010281;VRT-031745;cid_3038525;5-(2,6-DICHLOROPHENYL)-2-((2,4-DIFLUOROPHENYL)THIO)-6H-PYRIMIDO(1,6-B)PYRIDAZINE-6-ONE;GTPL5719;5-(2,6-Dichlorophenyl)-2-[2,4-difluorophenyl)thio]-6H-pyrimido[1,6-b]pyridazin-6-one;SB19425;5-(2,6-dichlorophenyl)-9-(2,4-difluorophenyl)sulfanyl-1,3,10-triazabicyclo[4.4.0]deca-2,5,7,9-tetraen-4-one;MFCD09834070;BRD-K91900765-001-01-9;AM84727;SMR004701351;HMS3884M17;AC-707;hexadecylacrylate;5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one;209410-46-8;DTXSID90175115;CCG-269082;VX-745, >=98% (HPLC);s1458;D10959;BDBM15244;SW219693-1;Kinome_3767;5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-6-pyrimido[1,6-b]pyridazinone;DB07138;NEFLAMAPIMOD [INN];UNII-TYL52QM320;Q27089208;EX-8451;HY-10328;BCP01837;HB1309;NSC-785334;EX-A854;NCGC00241111-01;VD-31;NS00070857;VD-31,745;5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]pyrimido[1,6-b]pyridazin-6-one;NCGC00241111-02;NEFLAMAPIMOD [WHO-DD];AKOS005766014;J-013730;VD-31745;5-(2,6-Dichlorophenyl)-2-[(2,4-Difluorophenyl)sulfanyl]-6h-Pyrimido[1,6-B]pyridazin-6-One;5-[2,6-bis(chloranyl)phenyl]-2-[2,4-bis(fluoranyl)phenyl]sulfanyl-pyrimido[1,6-b]pyridazin-6-one;CHEMBL119385;6H-Pyrimido(1,6-b)pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-((2,4-difluorophenyl)thio)-;FT-0654042;NSC785334;CS-0195;J-516084;CHEBI:90528;BCPP000015;A815037;5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylsulfanyl)-6h-pyrimido[3,4-b]pyridazin-6-one;HMS3295M13 |
| CAS号： | 209410-46-8 |
| 分子式： | C19H9CL2F2N3OS |
| 分子量： | 436.26 |
| 密度： | |
| 熔点： | |
| 沸点： | |
| 闪点： | |
| 水溶性： | |
| 蒸气压： |
VX-745
英文名：
VX-745
别名：5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基)-6H-嘧啶并[1,6-b]哒嗪-6-酮;4-肼基-N-甲基苯基乙烷磺酰胺盐酸盐;VX745 抑制剂
商品编号：R023546-10mg
规格：10mg
纯度：99%
CAS号： 209410-46-8
分子式：C19H9CL2F2N3OS
分子量：436.26
| 价格 |
¥ 902.00
（请 登录 会员查看折扣价）
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
¥ 902.00
